Valuation Basilea Pharmaceutica AG

Stocks

Market Closed - Swiss Exchange Other stock markets 11:31:36 2026-07-23 EDT			5-day change	1st Jan Change
52.30 ^CHF	0.00%		-0.19%	-4.39%

05-28	Basilea Pharmaceutica Ltd Receives Additional USD 13.3 Million From BARDA To Continue Development Of Novel Antibiotic Ceftibuten-Ledaborbactam Etzadroxil	CI
05-28	Basilea Pharmaceutica Gets Additional $13 Million Funding for Antibiotic Development	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	484.7	545.8	422.9	501.2	672.1	648.3	-	-
Change	-	12.62%	-22.52%	18.52%	34.1%	-3.55%	-	-
Enterprise Value (EV) ¹	552.8	630	473.9	472.6	585.2	496	435.7	441.2
Change	-	13.97%	-24.78%	-0.28%	23.84%	-15.24%	-12.16%	1.26%
P/E	-70.6x	44.9x	41x	7.09x	17.4x	13.9x	18.2x	38.6x
PBR	-	-	-42.3x	6.17x	5.26x	3.42x	2.52x	2.7x
PEG	-	-0x	-2.6x	0x	-0.4x	0.7x	-0.8x	-0.7x
Capitalization / Revenue	3.27x	3.69x	2.68x	2.4x	2.89x	2.47x	2.42x	3.21x
EV / Revenue	3.73x	4.26x	3.01x	2.27x	2.52x	1.89x	1.63x	2.18x
EV / EBITDA	287x	32.1x	22.8x	7.51x	11x	6.99x	10.7x	23.4x
EV / EBIT	461x	34.1x	24.7x	7.72x	11.4x	6.56x	10.2x	29.9x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.58	1.02	0.86	5.83	3.14	3.768	2.868	1.354
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	148.1	147.8	157.6	208.5	232.4	262.9	267.5	202.2
EBITDA ¹	1.926	19.64	20.78	62.91	53.36	70.97	40.87	18.82
EBIT ¹	1.2	18.5	19.2	61.2	51.5	75.66	42.6	14.78
Net income ¹	-6.8	12.15	10.5	77.6	40.2	51.57	39.24	18.54
Net Debt ¹	68.1	84.17	50.98	-28.65	-86.9	-152.3	-212.6	-207.1
Reference price ²	40.92	45.80	35.30	41.35	54.70	52.30	52.30	52.30
Nbr of stocks (in thousands)	11,844	11,918	11,980	12,121	12,288	12,396	-	-
Announcement Date	2/15/22	2/14/23	2/13/24	2/18/25	2/17/26	-	-	-

¹CHF in Million²CHF

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BASILEA PHARMACEUTICA AG	13.88x	1.89x	6.99x	-.--%	797M
LONZA GROUP AG	31.99x	5.69x	17.6x	1.03%	46.06B
REVOLUTION MEDICINES, INC.	-22.96x	333.54x	-20.89x	-.--%	38.91B
BEONE MEDICINES AG	48.28x	4.86x	31.12x	-.--%	35.57B
IQVIA HOLDINGS INC.	24.16x	2.71x	11.7x	-.--%	33.13B
CELLTRION, INC.	26.27x	7.71x	19.36x	0.43%	26.42B
MEDPACE HOLDINGS, INC.	31.03x	5.02x	22.85x	-.--%	15.08B
EUROFINS SCIENTIFIC SE	24.17x	2.07x	9.1x	1.09%	14.08B
ICON PUBLIC LIMITED COMPANY	23.64x	1.89x	11.43x	-.--%	12.81B
Average	22.27x	40.60x	12.14x	0.28%	24.76B
Weighted average by Cap.	22.05x	62.09x	11.80x	0.33%